Upregulation of Ecto-5′-Nucleotidase by Rosuvastatin Increases the Vasodilator Response to Ischemia

No abstract is available for this paper.

• Publication year

  2010

• Venue

  HYPERTENSION

• Publication date

  2010-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.110.155689PMID 20679180
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endothelial-Specific Deletion of Connexin40 Promotes Atherosclerosis by Increasing CD73-Dependent Leukocyte Adhesion

  2010cited by this paper
• Rosuvastatin Increases Extracellular Adenosine Formation in Humans In Vivo: A New Perspective on Cardiovascular Protection

  2009cited by this paper
• Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.

  2009cited by this paper
• Comparison of Arterial Functional Evaluations as a Predictor of Cardiovascular Events in Hypertensive Patients: The Non-Invasive Atherosclerotic Evaluation in Hypertension (NOAH) Study

  2008cited by this paper
• Caffeinated Coffee Blunts the Myocardial Protective Effects of Statins against Ischemia–Reperfusion Injury in the Rat

  2008cited by this paper
• Dipyridamole enhances ischaemia‐induced reactive hyperaemia by increased adenosine receptor stimulation

  2008cited by this paper
• The Cardioprotective Effect of a Statin and Cilostazol Combination: Relationship to Akt and Endothelial Nitric Oxide Synthase Activation

  2007cited by this paper
• Atorvastatin accelerates extracellular nucleotide degradation in human endothelial cells

  2007cited by this paper
• Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.

  2007cited by this paper
• Cardioprotection by Ecto-5′-Nucleotidase (CD73) and A2B Adenosine Receptors

  2007cited by this paper
• Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia.

  2007cited by this paper
• Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination.

  2007cited by this paper
• CD73/Ecto-5′-Nucleotidase Protects Against Vascular Inflammation and Neointima Formation

  2006cited by this paper
• Short duration of reactive hyperemia in the forearm of subjects with multiple cardiovascular risk factors.

  2006cited by this paper
• Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.

  2006cited by this paper
• High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.

  2005cited by this paper
• Reproducibility of blood flow and post-occlusive reactive hyperaemia as measured by venous occlusion plethysmography.

  2005cited by this paper
• Statins Are Associated With a Reduced Incidence of Perioperative Mortality After Coronary Artery Bypass Graft Surgery

  2004cited by this paper
• Optimal Windows of Statin Use for Immediate Infarct Limitation: 5′-Nucleotidase as Another Downstream Molecule of Phosphatidylinositol 3-Kinase

  2004cited by this paper
• Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention: Results From the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study

  2004cited by this paper
• Reactive hyperemia following coronary balloon angioplasty, but not dipyridamole-induced hyperemia, predicts resolution of exercise-induced ST-segment depression

  2003cited by this paper
• Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium

  2003cited by this paper
• Lovastatin Enhances Ecto-5′-Nucleotidase Activity and Cell Surface Expression in Endothelial Cells: Implication of Rho-Family GTPases

  2002cited by this paper
• Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects.

  2002cited by this paper
• Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function.

  2001cited by this paper
• Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

  2001cited by this paper
• Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

  2001cited by this paper
• Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• Activation of ecto‐5′‐nucleotidase by protein kinase C and its role in ischaemic tolerance in the canine heart

  1997cited by this paper
• Insights into thymic purine metabolism and adenosine deaminase deficiency revealed by transgenic mice overexpressing ecto-5'-nucleotidase (CD73).

  1997cited by this paper
• Blockade of vascular ATP-sensitive potassium channels reduces the vasodilator response to ischaemia in humans

  1996cited by this paper
• Simultaneous high-performance liquid chromatographic determination of caffeine and theophylline for routine drug monitoring in human plasma.

  1996cited by this paper
• Caffeine and theophylline attenuate adenosine‐induced vasodilation in humans

  1990cited by this paper
• A novel assay for 5'-nucleotidase using 1,N6-etheno-AMP as substrate, and comments on the properties of the reaction product, ethenoadenosine.

  1988cited by this paper
• Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function?

  1987cited by this paper
• The cardiovascular effects of regular and decaffeinated coffee.

  1985cited by this paper

• Caffeine Drug Interactions and its Clinical Implication After Acute Coronary Syndrome: A Literature Review

  2023cites this paper
• Statin treatment of patients with calcific aortic valve disease modulates extracellular adenosine metabolism on the cell surface of the aortic valve

  2020cites this paper
• Coffee, caffeine, chlorogenic acid, and the purinergic system.

  2019cites this paper
• Plasma levels of the cardiovascular protective endogenous nucleoside adenosine are reduced in patients with primary aldosteronism without affecting ischaemia‐reperfusion injury: A prospective case‐control study

  2019cites this paper
• Ectonucleotidases in Immunobiology

  2016cites this paper
• Effect of dipyridamole on myocardial reperfusion injury: A double‐blind randomized controlled trial in patients undergoing elective coronary artery bypass surgery

  2016cites this paper
• Targeting the adenosine system to limit ischemia-reperfusion injury : translational research in humans

  2016cites this paper
• Ticagrelor Does Not Inhibit Adenosine Transport at Relevant Concentrations: A Randomized Cross-Over Study in Healthy Subjects In Vivo

  2015cites this paper
• The Effect of Eplerenone on Adenosine Formation in Humans In Vivo: A Double-Blinded Randomised Controlled Study

  2014cites this paper
• The immunomodulatory actions of adenosine during systemic inflammation

  2014cites this paper
• Assessment of ischaemia and reperfusion injury

  2013cites this paper
• 5'-nucleotidases, nucleosides and their distribution in the brain: pathological and therapeutic implications.

  2013cites this paper
• Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes

  2012cites this paper
• Lipid-lowering therapy

  2012cites this paper
• Novel protective approaches in ischemia - reperfusion injury. In vivo studies in animals and humans

  2012influential citation
• Advances in Acute Coronary Syndrome Management

  2012cites this paper
• Atorvastatin does not affect ischaemia-induced phosphatidylserine exposition in humans in-vivo.

  2012cites this paper
• Targeting adenosine receptors in the development of cardiovascular therapeutics

  2012cites this paper
• Short-term Statin Treatment Does Not Prevent Ischemia and Reperfusion-induced Endothelial Dysfunction in Humans

  2012cites this paper
• How systemic inflammation modulates adenosine metabolism and adenosine receptor expression in humans in vivo

  2012cites this paper
• Regulation of leukocyte function by adenosine receptors.

  2011cites this paper
• NT5E mutations and arterial calcifications.

  2011cites this paper
• Links Between Insulin Resistance, Adenosine A2B Receptors, and Inflammatory Markers in Mice and Humans

  2011cites this paper
• Protection against skeletal muscle hypoperfusion by adenosine and nitric oxide: together alone?

  2011cites this paper
• Atorvastatin increases exercise leg blood flow in healthy adults.

  2011cites this paper
• The influence of high-dose simvastatin and diltiazem on myocardium in rabbits: a haemodynamic study

  2011cites this paper
• NT5E mutations and arterial calcifications.

  2011cites this paper
• The Anti-Ischemic and Anti-Anginal Properties of Statins

  2010cites this paper
• UNIVERSIDADE FEDERAL DE SANTA MARIA CENTRO DE CIÊNCIAS NATURAIS E EXATAS PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS BIOLÓGICAS BIOQUÍMICA TOXICOLÓGICA

  2008cites this paper